Source: https://tradeasduck.com/ideas/jnj/
Retrieved: 2026-11-19

[Archive](https://tradeasduck.com/ideas/) › JNJ

# JNJ trade ideas: every closed DuckWise idea on Johnson & Johnson

DuckWise has published 2 ideas on Johnson & Johnson (JNJ, Stock) that have closed between September 2019 and November 2019. Each is listed below with the levels published before the position was taken and its result at close — 2 in profit, 0 at a loss.

**2** closed ideas

**2 / 0** in profit / at a loss

**+3.29%** average result

**35 days** typical holding period

| Opened | Closed | Side | Entry | Stop | Projection | Close | Result | Days |
|---|---|---|---|---|---|---|---|---|
| Oct 22, 2019 | Nov 18, 2019 | Long | 129.95 | — | 198 | 133.89 | +3.03% | 27 |
| Sep 11, 2019 | Oct 16, 2019 | Long | 129.51 | — | 181.50 | 134.10 | +3.54% | 35 |

Prices in US dollars. Prices are as traded on the day. Result is the price change from the published entry to the published close plus dividends received while the idea was held (paid, for shorts), before fees, taxes and slippage. [How results are counted](https://tradeasduck.com/methodology/).

## JNJ questions and answers

### Has DuckWise published trade ideas on JNJ?

Yes. DuckWise has published 2 ideas on Johnson & Johnson (JNJ) that closed between September 2019 and November 2019: 2 closed in profit and 0 at a loss. The average result was +3.29% from the published entry to the published close, dividends included.

### What was the latest closed DuckWise idea on JNJ?

A long idea opened on October 22, 2019 with an entry of $129.95 and a price projection of $198.00. It closed on November 18, 2019 at $133.89, a result of +3.03% after 27 days.

### How long did DuckWise hold its JNJ ideas?

The typical JNJ idea was held about 35 days from entry to close. DuckWise ideas are swing and position trades, not day trades.

### Is there an open DuckWise idea on JNJ right now?

Not at the moment. When DuckWise publishes a new idea on JNJ, app subscribers get a push notification; it appears on this page once it closes.

### Is this page a stock forecast for JNJ or a recommendation to buy it?

No. This page records closed ideas only. Each price projection was a published level for a model idea, not a forecast of where JNJ will trade. The research is general and impersonal, not a recommendation to buy or sell JNJ or any other security.

## More trade ideas on the record
- [J](https://tradeasduck.com/ideas/j/) Jacobs Solutions Inc. · 1 idea
- [JAZZ](https://tradeasduck.com/ideas/jazz/) Jazz Pharmaceuticals plc · 1 idea
- [JD](https://tradeasduck.com/ideas/jd/) JD.com, Inc. · 14 ideas
- [KHC](https://tradeasduck.com/ideas/khc/) The Kraft Heinz Company · 2 ideas
- [KLAC](https://tradeasduck.com/ideas/klac/) KLA Corporation · 2 ideas
- [KMX](https://tradeasduck.com/ideas/kmx/) CarMax, Inc. · 1 idea
- [AMZN](https://tradeasduck.com/ideas/amzn/) Amazon.com, Inc. · 25 ideas
- [TSLA](https://tradeasduck.com/ideas/tsla/) Tesla, Inc. · 22 ideas
- [CRM](https://tradeasduck.com/ideas/crm/) Salesforce, Inc. · 18 ideas
- [LRCX](https://tradeasduck.com/ideas/lrcx/) Lam Research Corporation · 16 ideas
- [GOOG](https://tradeasduck.com/ideas/goog/) Alphabet Inc. · 15 ideas
- [ON](https://tradeasduck.com/ideas/on/) ON Semiconductor Corporation · 15 ideas
- [AAPL](https://tradeasduck.com/ideas/aapl/) Apple Inc. · 14 ideas
- [AMD](https://tradeasduck.com/ideas/amd/) Advanced Micro Devices, Inc. · 14 ideas

[Every ticker in the archive](https://tradeasduck.com/ideas/) · [Track record by year](https://tradeasduck.com/)

## About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. Pays a dividend yield of 1.88% annually.

These are closed ideas, published for the record. They are general and impersonal research, not a recommendation to buy or sell JNJ or any other security.

---
Model-portfolio results calculated from published entry and close levels plus dividends — not the returns of any real account; fees, taxes and slippage are not included; past results are not a reliable indicator of future results. General, impersonal research — not investment advice and not a recommendation to buy or sell any security.
